Here are three insights:
1. If coverage under reimbursement for medical devices isn’t certain, it becomes difficult to analyze the return on investment, limiting innovation.
2. Some medical device manufacturers are examining ways to reduce the medical reimbursement amount to prevent healthcare costs from increasing.
3. Medical device companies will have to move beyond products and devise business models to evolve in a value-driven healthcare ecosystem.
More articles on devices and implants:
Xtant Medical net sales decrease 12.6% in Q2: 5 things to know
Mazor Robotics, Zimmer Biomet, NuVasive & more: 11 device company key notes
ORHub names interim CFO & 5 more mid-year updates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
